Table 1 Patient characteristics in the derivation set
From: A prediction model for permanent pacemaker implantation after transcatheter aortic valve replacement
|  | Total (n = 336) | PPMI (n = 48) | No PPMI (n = 288) | p value |
|---|---|---|---|---|
Baseline characteristics and medical history | ||||
 Age, yrs | 75.69 ± 7.11 | 76.62 ± 6.87 | 75.53 ± 7.15 | 0.315 |
 Male | 142 (42.26%) | 16 (33.33%) | 126 (43.75%) | 0.168 |
 CAD | 271 (80.65%) | 37 (77.08%) | 234 (81.25%) | 0.527 |
 Diabetes | 84 (25%) | 7 (14.58%) | 77 (26.74%) | 0.039 |
 Hypertension | 191 (56.85%) | 27 (56.25%) | 164 (56.94%) | 0.929 |
 History of stroke | 18 (5.36%) | 3 (6.25%) | 15 (5.21%) | 0.783 |
 History of syncope | 34 (10.12%) | 6 (12.5%) | 28 (9.72%) | 0.590 |
 Atrial fibrillation | 68 (20.24%) | 12 (25%) | 56 (19.44%) | 0.413 |
 First degree AVB | 17 (5.06%) | 4 (8.33%) | 13 (4.51%) | 0.467 |
 LBBB | 7 (2.08%) | 0 (0%) | 7 (2.43%) | 0.008 |
 RBBB | 20 (5.95%) | 9 (18.75%) | 11 (3.82%) | 0.013 |
 eGFR, ml/min | 67.92 ± 22.32 | 65.88 ± 25.17 | 68.26 ± 21.83 | 0.539 |
Characteristics before TAVR | ||||
 Aortic annulus perimeter, mm | 80.56 ± 7.96 | 81.5 ± 6.94 | 80.41 ± 8.12 | 0.328 |
 Bicuspid aortic valve | 187 (55.65%) | 26 (54.17%) | 161 (55.90%) | 0.825 |
 AVA, cm2 | 0.71 ± 0.22 | 0.77 ± 0.27 | 0.7 ± 0.20 | 0.084 |
 LVEF, % | 58 ± 11 | 58 ± 11 | 58 ± 11 | 0.950 |
 TnT, ng/ml | 0.07 ± 0.20 | 0.08 ± 0.24 | 0.07 ± 0.20 | 0.811 |
 Transfemoral | 325 (96.73%) | 47 (97.92%) | 278 (96.53%) | 0.556 |
Characteristics after TAVR | ||||
 Self-expandable valve | 329 (97.92%) | 48 (100%) | 281 (97.57%) | 0.008 |
 Oversizing, % | 0.38 ± 7.86 | 1.37 ± 7.53 | 0.21 ± 7.91 | 0.315 |
 PNA, cm2 | 5.21 ± 0.95 | 5.46 ± 0.99 | 5.16 ± 0.94 | 0.058 |
 AVA, cm2 | 2.30 ± 0.61 | 2.33 ± 0.62 | 2.30 ± 0.61 | 0.701 |
 Implantation depth, mm | 5.22 ± 3.73 | 6.06 ± 3.56 | 5.08 ± 3.74 | 0.082 |
 TnT, ng/ml | 0.34 ± 0.45 | 0.44 ± 0.72 | 0.32 ± 0.39 | 0.267 |
 PLOS, day(s) | 7.23 ± 3.24 | 8.98 ± 3.64 | 6.94 ± 3.08 | < 0.001 |